sucralfate + oxetacaine + simethicone

Sucralfate + oxetacaine + simethicone is a fixed-dose combination oral suspension used for the management of gastrointestinal disorders including peptic ulcers, gastritis, and gastroesophageal reflux disease (GERD) associated with flatulence. **Sucralfate** acts as a cytoprotective agent by adhering to ulcer sites and forming a protective proteinaceous barrier against acid, pepsin, and bile salts. **Oxetacaine** (also known as oxethazaine) is a potent local anesthetic that provides rapid symptomatic relief from pain by numbing the esophageal and gastric mucosa; it is unique for maintaining its anesthetic activity even in highly acidic environments. **Simethicone** serves as an anti-foaming agent that reduces the surface tension of gas bubbles in the digestive tract, facilitating their coalescence and expulsion to relieve bloating and gas-related discomfort. This combination is primarily marketed in India by companies such as Laksun Lifesciences.

Other names

Sucralfate Oxetacaine Simethicone Syrupsucralfate + oxethazaine + simethicone